Cart
sales@molnova.com
Dihydroactinidiolide
CAS No. 17092-92-1
Dihydroactinidiolide( —— )
Catalog No. M18118 CAS No. 17092-92-1
Dihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 40 | In Stock |
|
| 100MG | 61 | In Stock |
|
| 200MG | 87 | In Stock |
|
| 500MG | 142 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydroactinidiolide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
-
DescriptionDihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17092-92-1
-
Formula Weight180.24
-
Molecular FormulaC11H16O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (554.82 mM)
-
SMILESCC1(CCC[C@@]2(C1=CC(=O)O2)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shumbe L, et al. Dihydroactinidiolide, a high light-induced β-carotene derivative that can regulate gene expression and photoacclimation in Arabidopsis. Mol Plant. 2014 Jul;7(7):1248-51.
molnova catalog
related products
-
Oxyphencyclimine Hyd...
Oxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.
-
653-47 hydrochloride
653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15.?
-
BAZ1A-IN-1
BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.
